Fevipiprant, a selective prostaglandin-D2 receptor-2 antagonist, inhibits human group-2 innate lymphoid cell aggregation and function
Tools
Hardman, Clare and Chen, Wentao and Luo, Jian and Batty, Paul and Chen, Li-Ying and Nahler, Janina and Wu, Yianqui and Erpenbeck, Veit and Sandham, David and Xue, Luzheng and Ogg, Graham (2019) Fevipiprant, a selective prostaglandin-D2 receptor-2 antagonist, inhibits human group-2 innate lymphoid cell aggregation and function. Journal of Allergy and Clinical Immunology. ISSN 00916749
Official URL: https://www.jacionline.org/article/S0091-6749(19)3...
Abstract
No abstract
Item Type: | Article |
---|---|
Date Deposited: | 23 Mar 2019 00:45 |
Last Modified: | 23 Mar 2019 00:45 |
URI: | https://oak.novartis.com/id/eprint/36996 |